Combined Intralipid-urotherapy for Patients with Cancer: A Creative Review
Joseph Eldor *
Theoretical Medicine Institute, Jerusalem, Israel
*Author to whom correspondence should be addressed.
Abstract
The article relates in general to intralipid and its use in cancer therapy. Specifically, it relates to the combined intralipid-urotherapy for treating cancer, and methods of such treatment.
Cancer cells release various antigens, some of which appear in the urine. Combined oral Intralipid and auto-urotherapy is suggested as a new treatment modality for cancer patients. It will provide the intestinal lymphatic system the many tumor antigens against which antibodies may be produced. These antibodies may be transpierced through the blood stream and attack the tumor and its cells.
Intralipid can increase the response to the cancer antigens in the intestinal lymphatic system against which antibodies may be produced.
Keywords: Cancer, auto- urotherapy, intralipid